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Abstract
Background: This randomized study was aimed to compare the diagnostic value of two head-
up  tilt  testing  protocols  using  sublingual  nitroglycerin  for  provocation  in  patients  with 
recurrent  unexplained syncope and normal  heart.                                        
Methods: The patients with normal findings in physical examination, electrocardiography and 
echocardiography were randomly submitted  to  one of upright  tilt  test  protocols.  The only 
difference between two protocols was that nitroglycerin was administered after a five minute 
resting phase in supine position during protocol B. We also considered eighty normal persons 
as  the  control  group.                                                
Results: Out of 290 patients that underwent tilt testing, 132 patients were in group A versus 
158 patients in group B. Both groups had an identical distribution of clinical characteristics. 
Tilt test was positive in 79 patients in group A (25 in passive phase, 54 in active phase) versus 
96 patients in group B (43 in passive phase, 53 in active phase). There was no significant 
difference  between  results  in  two groups  (P  value= 0.127).  Forty  cases  were  tested  with 
protocol A and forty underwent tilt testing with protocol B. Tilt test was positive in 4 cases 
with protocol A versus 3 cases in protocol B. The positive rates of tilt testing with protocol A 
was 60% while it was 61% in protocol B. The specificity of testing with protocol A was 90% 
and  it  was  92.5%  in  protocol  B.                                         
Conclusions: According to our data, adding a period of rest and returning to supine position 
before nitroglycerin administration had no additional diagnostic yield.                                  
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Introduction  
Neurally mediated syncope is the most common cause of syncope at any age and upright tilt 
testing has been one of the most common tests in assessing the patients  with unexplained 
syncope. [1,2] Many protocols have been proposed for this purpose and the Italian protocol 
has been suggested as the standard protocol.[3] But honestly, there is no real gold standard test 
and the results of several studies have shown conflicting results concerning sensitivity and 
specificity  of  the  test.                                              
Sublingual  nitroglycerin has become popular agent for potentiating of head-up tilt  tests in 
adults because of simplicity of use. Nitrates have vasodilatory effect especially on veins and 
this  effect  varies  in  different  positions.  [4,5]                                       
We hypothesized that the position of the patient during nitroglycerin administration may have 
some effect on sensitivity and specificity of upright tilt testing. In this study, we decided to 
compare the positive rate and specificity of two head-up tilt testing protocols using sublingual 
nitroglycerin as the provocative-agent in patients with normal heart and recurrent unexplained 
syncope. The only difference between these two protocols was the position of the patient at 
which nitroglycerin was administered. We hypothesized that this new protocol may have a 
better  specificity  than  the  other  protocol.                                          
Materials  and  Methods                                                  
Study  population                                            
We  considered  all  the  patients  that  were  referred  to  Jundishapur  University  and  Shiraz 
University  affiliated  hospitals  for  evaluation  of  syncope  from  1st  January  2009  to  31th 
December  2011.  All  cases  underwent  history  taking,  physical  examination,  neurologic 
assessment,  12-lead  conventional  electrocardiography  and  transthoracic  echocardiography. 
Exercise stress test was performed only when clinically indicated. The patients who had 1) age 
of  twenty-five  to  forty-five  2)  at  least  two  episodes  of  syncope  3)  normal  physical 
examination including supine and orthostatic blood pressure 4) normal electrocardiography 5) 
normal echocardiographic study were selected. The patients who had diabetes, autoimmune 
disease and neurologic disorders were excluded. We also excluded patients with clinically 
typical  neurally  mediated  syncope,  e.g.  the  patients  with  situational  syncope.        
All eligible subjects were randomized via random numbers table and allocated with sealed 
envelopes to either protocol A or protocol B and one week later, crossed over to the other 
protocol at the same time of the day. After testing 50 patients in each group, we compared the 
results in each group. There were no significant differences between the results. Hence, we 
performed only one upright tilt test in other patients in each group and compared the results of 
tests in group A versus group B. The main reason of this decision was decreasing of the time 
and  the  cost  needed  for  the  study.                                                  
We also considered eighty healthy cases with normal physical examination, normal 12-lead 
electrocardiography  and  transthoracic  echocardiography  that  did  not  have  any  episode  of 
syncope in the past as the control group. We select them among medical staff and students in 
age group of 25-45. Randomly, forty of them underwent upright tilt testing with protocol A 
and  the  rest  with  protocol  B.                                              
Head-up  tilt  test  with  nitroglycerin  provocation                               
We  used  a  tilt  table  with  footboard  support  located  in  a  quiet  room.  To  avoid  diurnal 
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autonomic variability interference,  we performed all  tests between 8 a.m. and 10 a.m. All 
cardiovascular drugs were withdrawn for at least 5 half-lives before the study. All cases had 
been fasting for at  least  four hours. Antecubital  venous cannulation was performed before 
resting phase and the electrocardiogram and blood pressure were measured and recorded by 
the  Task  Force  monitor  (CN  systems,  Graz,  Austeria).  Sublingual  spray  nitroglycerin 
(Nitromint,  EGIS Pharmaceuticals  PLC, Budapest,  Hungary)  was used as  the  provocative 
agent. Oral spray was chosen because its action is faster and its absorption is better.           
We used two head-up tilt  test  protocols  which were different  in  active  phase.            
Protocol A: Resting phase in supine position for 20 min after venous cannulation, Drug-free 
70º tilt for 45 min, Active 70º tilt phase (after 400 µg sublingual nitroglycerin administrations) 
for 15 min. This protocol is the protocol that routinely is used at Jundishapur University of 
Medical  Sciences.                                       
Protocol B: Resting phase in supine position for 20 min after venous cannulation, Drug-free 
70º tilt for 45 min, Resting phase in supine position for 5 min, Active 70º tilt phase (after 400 
µg  sublingual  nitroglycerin  administration)  for  15  min.                              
The  tilt  table  was lowered when a  positive  result  was developed or  when the  test  ended 
according  to  the  protocol.                                   
Definitions    
We defined syncope as sudden and transient loss of consciousness and postural tone followed 
by spontaneous recovery. Head-up tilt test was considered positive if syncope was reproduced 
in association with hypotension, bradycardia or both. [5]                                    
Ethics  
The study protocol was approved by ethics committee of Jundishapur University of Medical 
Sciences.  All  patients  provided written  informed  consent.                              
Statistical  analysis                                        
Continuous data were expressed as mean ± standard deviation values. Chi-square test and 
student T-test were used to compare groups. A P value less than 0.05 was considered to be 
statistically  significant.                                
Results
During the first part of the study, fifty patients underwent upright tilt test in each group and 
the test was repeated with the other protocol one week later. The demographic and clinical 
characteristics of the patients in these two groups and the results of two separate upright tilt  
tests in each group are shown in  Table 1 and  Table 2. There was no significant difference 
between demographic and clinical characteristics of the patients in both groups. The results of 
repeating upright tilt test were not significantly different from the results of first test. After 
that we decided to perform only one test on other patients in each group to decrease the time 
and  the  budget  needed  for  the  study.                                    
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Table 1: Baseline characteristics of the patients in group A versus the patients in group B 
during the first part of the study.
Table 2: Comparison of head-up tilt results in the patients in group A versus the patients in 
group B during the first part of the study.
NS: Not Significant
Overall two hundred ninety patients were enrolled. Head-up tilt  test was performed in one 
hundred thirty-two patients with protocol A and one hundred fifty-eight patients with protocol 
B. The demographic and clinical characteristics of the patients in group A and group B are 
shown in Table 3. There was no significant difference between two groups except in corrected 
QT interval, although both were within normal range. 
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Table 3: Baseline characteristics of patients in group A versus group B.
*Statistically significant difference between two groups (P<0.05).
Forty control cases underwent head-up tilt testing with protocol A. The mean age of this group 
was 29.9±10.2 years and the male/female ratio was 20(50%)/20(50%). On the other hand, 
forty control cases underwent tilt  testing with protocol B. The mean age of the group was 
29.3±11.1 years and the male/female ratio was 22(55%)/18(45%). All the echocardiographic 
and electrocardiographic  parameters  were within  normal  limits.                          
No serious side effect was observed during the study except for mild headaches in twenty-nine 
patients and six controls. 
 
The results of tilt testing in group A and group B are shown and compared in Table 4.
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Table 4: Comparison of head-up tilt results in group A versus group B.
The results of upright tilt test in both groups were not significantly different.                            
Among control group, four cases in protocol A group and three cases in protocol B group had 
positive  results.  The  syncope  occurred  in  all  of  these  persons  after  nitroglycerin 
administration.
Because  we  did  not  have  a  real  gold  standard  to  diagnose  the  vasovagal  syncope,  we 
considered comparison of the positive rate of tests with different protocols instead of their 
sensitivity. The positive rate of protocol A was 60% and the positive rate of protocol B was 
61%. The specificity of protocol A was 90% and on the other hand, the specificity of protocol 
B  was  92.5%.                                    
To compare the effect of patient's position at the time of drug administration on test results in 
active phase, we excluded the patients with positive result in passive phase of tilt test and 
repeated the comparison. Out of 107 patients in group A, 53 patients had negative results and 
54 patients had positive results in active phase and out of 115 patients in group B, 62 patients 
had negative results and 53 patients had positive results. The difference between two groups 
was no significant (P value: 0.652). According to these results, the positive rate of protocol A 
in active phase was 50% and the positive rate of protocol  B was 46%.                  
We compared the patients' characteristics in cases with positive upright tilt test with the cases 
without positive results (Table 5). The only difference was the history of traumatic syncope 
that was more prevalent in patients with positive upright tilt test result. Age, gender, time from 
the first syncope, time from the last syncope and number of syncopal attacks did not have any 
relation  with  positive  upright  tilt  test  results.                            
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Table 5: The relation between results and clinical characteristics of patients in group A and 
group B
*Statistically significant difference between two groups (P<0.05).
We followed all the patients for one year. No arrhythmia or pacemaker implantation had been 
reported.  
Discussion
Neurally  mediated syncope is  the most frequent  cause of syncope,  particularly in patients 
without structural heart disease.[1] The real mechanism of neurally mediated syncope is still a 
matter  of  discussion.  It  is  considered  that  it  can  be  initiated  by  venous  pooling,  with  a 
subsequent reduced blood volume and increased sympathetic activity that in the susceptible 
persons  can  result  in  paradoxical  activation  of  the  ventricular  mechanoreceptors  with 
inhibitory afferents to cardiovascular brainstem centers, which are ultimately responsible for 
the triggering of bradycardia or hypotension or both.[1] Other factors such as neurohumoral 
activation  and  higher  central  nervous  centers  could  also  contribute.  [1]                 
Head-up tilt testing is the most popular technique for the detection of this common type of 
syncope  although  there  are  wide  variations  in  protocols  and  provocative  agents  used  in 
different centers. [2-14] While upright tilt test with the Italian protocol has been proposed as 
the standard method of upright tilt test in vasovagal syncope evaluation,[3] there is not a real 
gold standard test for diagnosis of neurally mediated syncope.                                
Sublingual nitroglycerin has become the most common agent for potentiating of head- up tilt  
testing in adults  because of its  convenience and safety.  Because of its  potent  vasodilatory 
effect in the capacity vessels, nitrates increase venous pooling already enhanced by the upright 
posture and can increase the sensitivity of test.[1] Nitrates are lipid soluble and readily cross 
the  blood-to-brain barrier,  so nitrates  may have  a  central  role  in  tilt  test  potentiation.[15] 
Nitrate potentiated tilt testing has been used in many studies with various protocols. In most 
protocols sublingual nitrate was administered in the standing position without returning to a 
supine position. [15] We hypothesized that the total amount of orthostatic stress was less in 
protocols that lower the table before drug administration. On the other hand, as mentioned 
before, nitrates may potentiate the test with central role that is not related to the position of the 
patient. The present study was designed to determine the inﬂuence of patient's position before 
nitrate administration on test results. As a matter of fact, we wanted to compare the positive 
rate  of  a  protocol  with  probable  better  specificity  (protocol  B)  with  the  routine  protocol 
(protocol A). The only difference between two protocols we used was the position of patient 
before drug administration. To best of our knowledge, a comparison between diagnostic yields 
of  these  two  protocols  of  tilts  had  never  been  performed.                            
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According to  our  data,  reproducibility  of  the test  results  was excellent  compared to  other 
studies that showed a reproducibility rate of 80% for positive results. [2]                  
In our study, the positive rates in protocol A were 60% versus 61% in protocol B which were 
similar  to  previous  studies  (61-69%).[3]  The  specificity  of  upright  tilt  testing  with  the 
common protocols has been reported 92-94%.3 According to this study, the specificity of tilt 
testing  with  protocol  A  was  90%.  On  the  other  hand,  the  specificity  of  tilt  testing  with 
protocol  B was 92.5% that  was not  significantly different  from the protocol A.          
We also measured the positive test rates in active phase to compare the two protocols after 
drug provocation. The positive rate in upright tilt testing with protocol A was 50%, while the 
positive rate in protocol B was 46%. It means that adding a period of rest to the common tilt 
testing  protocol  not  only do not  increase  the specificity  of test  but also may decrease  its 
sensitivity.
In  our  study,  sublingual  nitroglycerine  was  safe  and  well  tolerated.  In  fact,  after  drug 
administration,  the  test  was  complicated  by  headache  in  thirty-five  patients  (9%),  which 
nevertheless  did  not  request  test  interruption.                                
Study  limitations                                   
One major limitation of the present study is that the mean age of our patients was low and the 
results cannot be applied to all patients with vasovagal syncope. The relatively small number 
of  patients  in  each  subgroup  is  another  limitation  for  an  adequate  statistical  analysis.  
Conclusion  
According to our data, adding a period of rest to head-up tilt testing protocol and returning to 
supine  position  before  nitroglycerin  administration  had  no  additional  diagnostic  yield.  
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